TrialJournal of diabetes investigation2023

Changes in glycemic control and skeletal muscle mass indices after dapagliflozin treatment in individuals with type 1 diabetes mellitus.

Yuta Yoshimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.